INCR
InterCure Ltd.
5.40$
+1.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.9% | -6.6% | -5.8% | +0.0% | +2.9% | +0.0% | -1.4% | +0.0% | -8.1% | +0.0% | +0.0% | |
| – | -7.4% | +6.2% | -11.5% | +0.0% | +5.7% | +0.0% | -4.5% | +0.0% | -15.3% | +0.0% | +0.0% | |
| – | -3.5% | -1.5% | -80.3% | +0.0% | +295.3% | -0.4% | -34.5% | +0.0% | -9.5% | +0.0% | +0.0% | |
| – | -3.5% | -1.5% | -80.0% | +0.0% | +287.5% | – | – | +0.0% | -9.5% | – | – | |
| – | -20.6% | -54.5% | +0.9% | +0.0% | -14.9% | -1.2% | -9.5% | +0.0% | -53.6% | -2.8% | +629.4% | |
| – | +5.2% | -26.5% | +19.9% | +2.7% | -7.4% | +4.2% | +18.2% | +0.0% | -27.1% | +0.1% | +0.0% | |
| – | -4.3% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -22.2% | +1.1% | +0.0% | +0.4% | +0.0% | +0.1% | +0.0% | -2.5% | +0.0% | +0.0% | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -10.9% | +4.9% | -15.4% | +0.0% | +30.9% | +0.0% | -12.4% | +0.0% | -7.9% | +0.0% | +0.0% | |
| – | -11.0% | +8.7% | -7.5% | +0.0% | +8.6% | +0.0% | -10.9% | +0.0% | +6.1% | +0.0% | +0.0% | |
| – | -25.1% | +61.5% | -11.9% | +0.0% | -9.2% | – | – | +0.0% | +65.8% | – | – | |
| – | +5.7% | -25.0% | +5.9% | +0.0% | -6.7% | +0.0% | +17.1% | +0.0% | -24.9% | +0.0% | +0.0% | |
| – | -12.4% | – | – | – | – | – | – | – | – | – | – | |
| – | +1.2% | -10.5% | +1.2% | +0.0% | -13.8% | +0.0% | +8.6% | +0.0% | -8.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +4.7% | +6.6% | +0.0% | -7.9% | +436.3% | -75.9% | +0.0% | -10.8% | +439.4% | -81.5% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.